SCHEMBL2432368

SCHEMBL2432368

Oc1cc[c]c(-c2cccc(-c3ccccc3)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.47
HSD17B2 P37059 6/20 0.47
ESR1 P03372 3/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ESR2 Q92731 2/20 0.44
ABL1 P00519 1/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
KMO O15229 1/20 0.40
MMP3 P08254 1/20 0.40
BCL2L1 Q07817 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
ACMSD Q8TDX5 1/20 0.40
ALOX5 P09917 2/20 0.39
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8471292 0.88 ALOX5 (0.43) HSD17B1HSD17B2ESR1CYP3A4CYP2C9
SCHEMBL6061090 0.86 HSD17B1 (0.52) HSD17B1HSD17B2ESR1CYP3A4CYP2C9
SCHEMBL16719879 0.80 ESR2 (0.52) HSD17B1HSD17B2CYP3A4CYP2C9MEN1
SCHEMBL5217872 0.80 ACHE (0.50) HSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL2341383 0.78 MMP3 (0.56) HSD17B1HSD17B2ESR1CYP3A4CYP2C9
SCHEMBL26567 0.76 MAOA (0.41) ESR1MEN1KMT2AKMOHDAC4
SCHEMBL589437 0.76 MAOA (0.41) ESR1MEN1KMT2AKMOHDAC4
SCHEMBL1451004 0.76 ALDH1A1 (0.43) ESR1CYP3A4MEN1KMT2AESR2
SCHEMBL19845791 0.75 HSD17B1 (0.80) HSD17B1HSD17B2ESR1CYP3A4CYP2C9
SCHEMBL11819204 0.75 HSD17B1 (0.80) HSD17B1HSD17B2ESR1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542076-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS Merck Sharp & Dohme Corp. (US) 2013-01-09 EP disclosed
WO-2011109254-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed